• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VBS
Click for more information
0.00% 8.0¢

VECTUS BIOSYSTEMS LIMITED - Announcements

Market Cap $4.256M  ! watchlist Created with Sketch. Add to my watchlist

Vectus Biosystems Limited is an Australia-based drug discovery and development company.... Vectus Biosystems Limited is an Australia-based drug discovery and development company. The Company focuses on medical research and development. It is engaged in developing a treatment for fibrosis and high blood pressure, which includes the treatment for diseases in the fibrotic market, namely heart, kidney, and liver diseases. Its compound, VB0004, focuses on treating the hardening of functional tissue and high blood pressure. It also focuses on developing candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH) as well as pulmonary fibrotic diseases. The Company has also developed technology focused at improving the speed and accuracy of measuring the amount of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in samples tested in laboratories. Accugen is a platform, developed by its wholly owned subsidiary, Accugen Pty Limited, comprising of reagents, and software that quantitate polymerase chain reaction (qPCR) reactions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
VBS Half Year Report and Appendix 4DPRICE SENSITIVE28/02/19
VBS Response to ASX Appendix 4C QueryPRICE SENSITIVE22/02/19
VBS Appendix 4C - Quarterly ReportPRICE SENSITIVE31/01/19
VBS Results of Meeting14/11/18
VBS CEO's Address to ShareholdersPRICE SENSITIVE14/11/18
VBS Chairman's Address to ShareholdersPRICE SENSITIVE14/11/18
VBS Appendix 4C - quarterlyPRICE SENSITIVE31/10/18
VBS Notice of Annual General Meeting and Proxy Form12/10/18
VBS 2018 Corporate Governance Statement and Appendix 4G12/10/18
VBS Annual Report to shareholders12/10/18
VBS Appendix 3B - Issue under EIP12/10/18
VBS Full Year Statutory Accounts28/09/18
VBS Director Retirement & Final Director's Interest Notice - GM31/08/18
VBS Preliminary Final ReportPRICE SENSITIVE31/08/18
VBS Appendix 4C - quarterlyPRICE SENSITIVE31/07/18
VBS Appendix 4C - quarterlyPRICE SENSITIVE30/04/18
VBS Appendix 3B End Escrow and Issue under EIP08/03/18
VBS Half Year Report and Appendix 4DPRICE SENSITIVE28/02/18
VBS Appendix 4C - quarterlyPRICE SENSITIVE31/01/18
VBS Release of Restricted Securities from Escrow24/01/18
VBS Results of Meeting16/11/17
VBS Chairman and CEO Addresses to AGM16/11/17
VBS Appendix 4C - QuarterlyPRICE SENSITIVE31/10/17
VBS Successful Pre-Clinical Trial and Granting of Key PatentPRICE SENSITIVE20/10/17
VBS Notice of Annual General Meeting/Proxy Form16/10/17
VBS 2017 Corporate Governance Statement13/10/17
VBS Annual Report to shareholders13/10/17
VBS Full Year Statutory Accounts28/09/17
VBS Preliminary Final ReportPRICE SENSITIVE31/08/17
VBS Appendix 4C - quarterlyPRICE SENSITIVE31/07/17
VBS Appendix 3B - Issue of Options05/06/17
VBS Appendix 4C - Quarterly Report and UpdatePRICE SENSITIVE28/04/17
VBS Half Yearly Report and Appendix 4DPRICE SENSITIVE28/02/17
VBS Response to ASX Appendix 4C QueryPRICE SENSITIVE13/02/17
VBS Appendix 4C - quarterlyPRICE SENSITIVE30/01/17
VBS Appendix 3B Issue of EIP Shares and Options27/01/17
VBS Change of Director's Interest Notice KD MS PB05/12/16
VBS Appendix 3B05/12/16
VBS Results of Annual General Meeting17/11/16
VBS Presentations to AGM17/11/16
VBS Response to ASX Appendix 4C QueryPRICE SENSITIVE14/11/16
VBS Vectus Wins Award08/11/16
VBS Appendix 4C - quarterly-VBS.AX PRICE SENSITIVE31/10/16
VBS Presentation to Brokers-VBS.AX 20/10/16
VBS Director Resignation and Appendix 3Z-VBS.AX 20/10/16
VBS Notice of Annual General Meeting/Proxy Form-VBS.AX 17/10/16
VBS Annual Report to shareholders-VBS.AX 30/09/16
VBS 2016 Corporate Governance Statement and Appendix 4G-VBS.AX 30/09/16
VBS Ceasing to be a substantial holder-VBS.AX 26/09/16
VBS Preliminary Final Report-VBS.AX PRICE SENSITIVE31/08/16
VBS Appendix 3B-VBS.AX 12/08/16
VBS Appendix 4C - quarterly-VBS.AX PRICE SENSITIVE29/07/16
VBS Appendix 3B Release of Securities from Escrow-VBS.AX 01/07/16
VBS Release of Restricted Securities from Escrow-VBS.AX 10/06/16
VBS Change of Director's Interest Notice - SP-VBS.AX 02/06/16
VBS New Director and Initial Director's Interest Notice-VBS.AX 05/05/16
VBS Appendix 4C - quarterly-VBS.AX PRICE SENSITIVE29/04/16
VBS TechVoucher Awarded to Accugen22/03/16
VBS Scientific Paper on Accugen TechnologyPRICE SENSITIVE15/03/16
VBS Key Accugen Patent Granted in USAPRICE SENSITIVE07/03/16
VBS Update Following Debut on ASX29/02/16
VBS Initial Director's Interest Notice - GM29/02/16
VBS Initial Director's Interest Notice - KD29/02/16
VBS Initial Director's Interest Notice - RS26/02/16
VBS Initial Director's Interest Notice - MS26/02/16
VBS Initial Director's Interest Notice - BS26/02/16
VBS Initial Director's Interest Notice - PB26/02/16
VBS Becoming a substantial holder BS26/02/16
VBS Becoming a substantial holder26/02/16
VBS Becoming a substantial holder25/02/16
VBS Becoming a substantial holder KD25/02/16
VBS Updated Statement of Commitments22/02/16
VBS Updated Pro Forma Statement of Financial Position22/02/16
VBS Statement re Issue of Securities to Lead Manager22/02/16
VBS Statement Regarding ASX Restricted Securities22/02/16
VBS Top 20 Holders22/02/16
VBS Distribution Schedule22/02/16
VBS Terms and Conditions of Performance Rights22/02/16
VBS Employee Incentive Plan Rules22/02/16
VBS Securities Trading Policy22/02/16
VBS Financial Report 30 June 201522/02/16
VBS Financial Report 30 June 201422/02/16
VBS Financial Report 30 June 201322/02/16
VBS Information Form and Checklist22/02/16
VBS Appendix 1A22/02/16
VBS Constitution22/02/16
VBS Replacement Prospectus22/02/16
VBS Admission to Official ListPRICE SENSITIVE22/02/16
VBS ASX Notice - Admission & Commencement of Official Quotation22/02/16
VBS Half Year Report and Appendix 4D
28/02/19PRICE SENSITIVE
VBS Response to ASX Appendix 4C Query
22/02/19PRICE SENSITIVE
VBS Appendix 4C - Quarterly Report
31/01/19PRICE SENSITIVE
VBS Results of Meeting
14/11/18
VBS CEO's Address to Shareholders
14/11/18PRICE SENSITIVE
VBS Chairman's Address to Shareholders
14/11/18PRICE SENSITIVE
VBS Appendix 4C - quarterly
31/10/18PRICE SENSITIVE
VBS Notice of Annual General Meeting and Proxy Form
12/10/18
VBS 2018 Corporate Governance Statement and Appendix 4G
12/10/18
VBS Annual Report to shareholders
12/10/18
VBS Appendix 3B - Issue under EIP
12/10/18
VBS Full Year Statutory Accounts
28/09/18
VBS Director Retirement & Final Director's Interest Notice - GM
31/08/18
VBS Preliminary Final Report
31/08/18PRICE SENSITIVE
VBS Appendix 4C - quarterly
31/07/18PRICE SENSITIVE
VBS Appendix 4C - quarterly
30/04/18PRICE SENSITIVE
VBS Appendix 3B End Escrow and Issue under EIP
08/03/18
VBS Half Year Report and Appendix 4D
28/02/18PRICE SENSITIVE
VBS Appendix 4C - quarterly
31/01/18PRICE SENSITIVE
VBS Release of Restricted Securities from Escrow
24/01/18
VBS Results of Meeting
16/11/17
VBS Chairman and CEO Addresses to AGM
16/11/17
VBS Appendix 4C - Quarterly
31/10/17PRICE SENSITIVE
VBS Successful Pre-Clinical Trial and Granting of Key Patent
20/10/17PRICE SENSITIVE
VBS Notice of Annual General Meeting/Proxy Form
16/10/17
VBS 2017 Corporate Governance Statement
13/10/17
VBS Annual Report to shareholders
13/10/17
VBS Full Year Statutory Accounts
28/09/17
VBS Preliminary Final Report
31/08/17PRICE SENSITIVE
VBS Appendix 4C - quarterly
31/07/17PRICE SENSITIVE
VBS Appendix 3B - Issue of Options
05/06/17
VBS Appendix 4C - Quarterly Report and Update
28/04/17PRICE SENSITIVE
VBS Half Yearly Report and Appendix 4D
28/02/17PRICE SENSITIVE
VBS Response to ASX Appendix 4C Query
13/02/17PRICE SENSITIVE
VBS Appendix 4C - quarterly
30/01/17PRICE SENSITIVE
VBS Appendix 3B Issue of EIP Shares and Options
27/01/17
VBS Change of Director's Interest Notice KD MS PB
05/12/16
VBS Appendix 3B
05/12/16
VBS Results of Annual General Meeting
17/11/16
VBS Presentations to AGM
17/11/16
VBS Response to ASX Appendix 4C Query
14/11/16PRICE SENSITIVE
VBS Vectus Wins Award
08/11/16
VBS Appendix 4C - quarterly-VBS.AX
31/10/16PRICE SENSITIVE
VBS Presentation to Brokers-VBS.AX
20/10/16
VBS Director Resignation and Appendix 3Z-VBS.AX
20/10/16
VBS Notice of Annual General Meeting/Proxy Form-VBS.AX
17/10/16
VBS Annual Report to shareholders-VBS.AX
30/09/16
VBS 2016 Corporate Governance Statement and Appendix 4G-VBS.AX
30/09/16
VBS Ceasing to be a substantial holder-VBS.AX
26/09/16
VBS Preliminary Final Report-VBS.AX
31/08/16PRICE SENSITIVE
VBS Appendix 3B-VBS.AX
12/08/16
VBS Appendix 4C - quarterly-VBS.AX
29/07/16PRICE SENSITIVE
VBS Appendix 3B Release of Securities from Escrow-VBS.AX
01/07/16
VBS Release of Restricted Securities from Escrow-VBS.AX
10/06/16
VBS Change of Director's Interest Notice - SP-VBS.AX
02/06/16
VBS New Director and Initial Director's Interest Notice-VBS.AX
05/05/16
VBS Appendix 4C - quarterly-VBS.AX
29/04/16PRICE SENSITIVE
VBS TechVoucher Awarded to Accugen
22/03/16
VBS Scientific Paper on Accugen Technology
15/03/16PRICE SENSITIVE
VBS Key Accugen Patent Granted in USA
07/03/16PRICE SENSITIVE
VBS Update Following Debut on ASX
29/02/16
VBS Initial Director's Interest Notice - GM
29/02/16
VBS Initial Director's Interest Notice - KD
29/02/16
VBS Initial Director's Interest Notice - RS
26/02/16
VBS Initial Director's Interest Notice - MS
26/02/16
VBS Initial Director's Interest Notice - BS
26/02/16
VBS Initial Director's Interest Notice - PB
26/02/16
VBS Becoming a substantial holder BS
26/02/16
VBS Becoming a substantial holder
26/02/16
VBS Becoming a substantial holder
25/02/16
VBS Becoming a substantial holder KD
25/02/16
VBS Updated Statement of Commitments
22/02/16
VBS Updated Pro Forma Statement of Financial Position
22/02/16
VBS Statement re Issue of Securities to Lead Manager
22/02/16
VBS Statement Regarding ASX Restricted Securities
22/02/16
VBS Top 20 Holders
22/02/16
VBS Distribution Schedule
22/02/16
VBS Terms and Conditions of Performance Rights
22/02/16
VBS Employee Incentive Plan Rules
22/02/16
VBS Securities Trading Policy
22/02/16
VBS Financial Report 30 June 2015
22/02/16
VBS Financial Report 30 June 2014
22/02/16
VBS Financial Report 30 June 2013
22/02/16
VBS Information Form and Checklist
22/02/16
VBS Appendix 1A
22/02/16
VBS Constitution
22/02/16
VBS Replacement Prospectus
22/02/16
VBS Admission to Official List
22/02/16PRICE SENSITIVE
VBS ASX Notice - Admission & Commencement of Official Quotation
22/02/16
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.256M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
VBS (ASX) Chart

Top Stories

Nanocap Si6 Metals to kick off drilling at Monument gold project WA, chasing past hits

Nanocap Si6 Metals (ASX:SI6) is on the cusp of kicking off drilling at its Monument project in WA, sniffing after historical gold hit targets.
Bitcoin jumps 8% to beat record on Trump vote optimism Bitcoin has been a big winner on financial markets today, tracking Donald Trump's election highs with an 8% rise and beating a previous record
The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint Let’s get straight to the point: of all the smallcaps in the Telecommunications index, The Market Ltd could be one of the most overlooked.
Lord picks up high-grade copper play in Western Australia, with past intercepts of up to 6.62% Lor Resources Ltd has entered into a binding earn-in agreement with Blackrock Resources Pty Ltd to take on up to 80% of the Ilgarari project
Palladium's the newest geopolitical hot commodity. But ASX exposure is limited On October 24, the USA reportedly approached its G7 counterparts and proposed a ban on Russian titanium, and, palladium.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.